Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.

Xiang B, Baybutt TR, Berman-Booty L, Magee MS, Waldman SA, Alexeev VY, Snook AE.

J Immunol. 2017 May 1;198(9):3507-3514. doi: 10.4049/jimmunol.1502672. Epub 2017 Mar 24.

PMID:
28341670
2.

Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.

Morabito KM, Ruckwardt TR, Redwood AJ, Moin SM, Price DA, Graham BS.

Mucosal Immunol. 2017 Mar;10(2):545-554. doi: 10.1038/mi.2016.48. Epub 2016 May 25.

3.

Oral Vaccination of Fish - Antigen Preparations, Uptake, and Immune Induction.

Mutoloki S, Munang'andu HM, Evensen Ø.

Front Immunol. 2015 Oct 19;6:519. doi: 10.3389/fimmu.2015.00519. eCollection 2015. Review.

4.

The Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8+ T Cells Measured Using Fluidigm Dynamic Arrays.

Trivedi S, Ranasinghe C.

PLoS One. 2015 May 6;10(5):e0126487. doi: 10.1371/journal.pone.0126487. eCollection 2015.

5.

Evolutionary Analysis and Prediction of Peptide Vaccine Candidates for Foot-and-Mouth-Disease Virus Types A and O in Bangladesh.

Momtaz S, Rahman A, Sultana M, Hossain MA.

Evol Bioinform Online. 2014 Nov 3;10:187-96. doi: 10.4137/EBO.S17027. eCollection 2014.

6.

Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Nizard M, Diniz MO, Roussel H, Tran T, Ferreira LC, Badoual C, Tartour E.

Hum Vaccin Immunother. 2014;10(8):2175-87. doi: 10.4161/hv.29269. Review.

7.

How can we design better vaccines to prevent HIV infection in women?

Rafferty H, Sibeko S, Rowland-Jones S.

Front Microbiol. 2014 Nov 4;5:572. doi: 10.3389/fmicb.2014.00572. eCollection 2014. Review.

8.

Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection.

Poles J, Alvarez Y, Hioe CE.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1027-40. doi: 10.1089/aid.2014.0233. Review.

9.

The influence of delivery vectors on HIV vaccine efficacy.

Ondondo BO.

Front Microbiol. 2014 Aug 22;5:439. doi: 10.3389/fmicb.2014.00439. eCollection 2014. Review.

10.

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.

Gu L, Krendelchtchikova V, Krendelchtchikov A, Oster RA, Fujihashi K, Matthews QL.

Virol J. 2014 Jun 16;11:112. doi: 10.1186/1743-422X-11-112.

11.
12.

Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination.

Li AV, Moon JJ, Abraham W, Suh H, Elkhader J, Seidman MA, Yen M, Im EJ, Foley MH, Barouch DH, Irvine DJ.

Sci Transl Med. 2013 Sep 25;5(204):204ra130. doi: 10.1126/scitranslmed.3006516.

13.

Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors.

Sandoval F, Terme M, Nizard M, Badoual C, Bureau MF, Freyburger L, Clement O, Marcheteau E, Gey A, Fraisse G, Bouguin C, Merillon N, Dransart E, Tran T, Quintin-Colonna F, Autret G, Thiebaud M, Suleman M, Riffault S, Wu TC, Launay O, Danel C, Taieb J, Richardson J, Zitvogel L, Fridman WH, Johannes L, Tartour E.

Sci Transl Med. 2013 Feb 13;5(172):172ra20. doi: 10.1126/scitranslmed.3004888. Erratum in: Sci Transl Med. 2013 Mar 27;5(178):178er2. Suleman, Muhammed [corrected to Suleman, Muhammad].

14.

Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.

Çuburu N, Graham BS, Buck CB, Kines RC, Pang YY, Day PM, Lowy DR, Schiller JT.

J Clin Invest. 2012 Dec;122(12):4606-20. doi: 10.1172/JCI63287. Epub 2012 Nov 12.

15.

Engineering nano- and microparticles to tune immunity.

Moon JJ, Huang B, Irvine DJ.

Adv Mater. 2012 Jul 24;24(28):3724-46. doi: 10.1002/adma.201200446. Epub 2012 May 29. Review.

16.

Vaccine design for CD8 T lymphocyte responses.

Koup RA, Douek DC.

Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007252. doi: 10.1101/cshperspect.a007252. Review.

17.

Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa.

Strbo N, Vaccari M, Pahwa S, Kolber MA, Fisher E, Gonzalez L, Doster MN, Hryniewicz A, Felber BK, Pavlakis GN, Franchini G, Podack ER.

Vaccine. 2011 Mar 21;29(14):2619-25. doi: 10.1016/j.vaccine.2011.01.044. Epub 2011 Jan 28.

18.

Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells.

Hong B, Song XT, Rollins L, Berry L, Huang XF, Chen SY.

J Clin Invest. 2011 Feb;121(2):739-51. doi: 10.1172/JCI42656. Epub 2011 Jan 4.

19.

Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques.

Morrow MP, Yan J, Pankhong P, Ferraro B, Lewis MG, Khan AS, Sardesai NY, Weiner DB.

Clin Vaccine Immunol. 2010 Oct;17(10):1493-9. doi: 10.1128/CVI.00181-10. Epub 2010 Aug 4.

20.

Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin.

Surman SL, Brown SA, Jones BG, Woodland DL, Hurwitz JL.

AIDS Res Hum Retroviruses. 2010 Jul;26(7):783-93. doi: 10.1089/aid.2009.0266.

Supplemental Content

Support Center